Evidence of tissue injury and an opinion about what caused that injury are related but separate propositions. A 2025 report of gastrointestinal illness in a person with methamphetamine exposure offers a concrete example of that distinction. The case is informative without being a controlled experiment or a validated diagnostic rule.
What did the case report document?
Johnsen and colleagues described one 48-year-old man with two weeks of episodic abdominal pain, nausea and hematemesis. Urine confirmation reported methamphetamine at 988 ng/mL and amphetamine at 776 ng/mL. CT findings prompted concern for malignancy; endoscopy identified ulceration and diffuse mucosal pallor without masses or strictures.
Upper-tract biopsies showed inflammation and intestinal metaplasia without dysplasia or malignancy. H. pylori staining was positive at the gastroesophageal junction but negative in the antral ulcer. No colonic biopsies were obtained. The authors attributed the diffuse presentation to methamphetamine-associated ischemia. The patient was lost to follow-up, so the planned repeat endoscopy did not establish healing after cessation. This was a single clinical attribution, not a measured dose-response or experimental demonstration of causation.
Why should the pathology and causal opinion be quoted separately?
A report may contain direct observations, interpretations of those observations and a final clinical impression. A careful summary identifies which is which. Describing a biopsy as having “proved methamphetamine injury” would require evidence that the observed tissue pattern uniquely identified that drug as the cause.
This is a methodological distinction, not a finding that the treating team’s interpretation was wrong. Clinical reasoning commonly combines several kinds of evidence. A forensic assessment should make that reasoning visible so another reviewer can examine the assumptions connecting observation to attribution.
What does the toxicology contribute?
The specimen and analyte must remain attached to the result. A urine concentration should not be relabeled as a blood concentration or treated as a directly measured dose. Nor does confirmation alone supply an exact time of use or quantify functional impairment at a different event.
These distinctions matter particularly when a chronology is disputed. Before making a timing claim, identify the evidence used to establish the sequence of exposure, symptoms, testing and treatment. State uncertainty where the sequence is incompletely documented.
Does improvement after treatment prove a proposed cause?
To evaluate a claimed response to removal of an exposure, first establish that the relevant follow-up observation actually occurred. A scheduled test is different from a completed test. A plan to check recovery cannot be reported as evidence of recovery.
Even when follow-up exists, interpretation should consider the other interventions and changes occurring during the same period. A temporal sequence can support an explanation without uniquely identifying it.
How can this case be used responsibly?
It can illustrate a possible presentation and the reasoning used in one evaluation. It cannot provide a frequency estimate, establish a concentration threshold for gastrointestinal injury, or resolve another patient’s differential diagnosis by analogy alone.
For record review, request the original pathology report, toxicology method and specimen information, imaging and endoscopy reports, treatment chronology and completed follow-up. The purpose is to distinguish documented findings from assumptions added later.
Scientific source
Johnsen N, Chang A, Chuang K, Patel S, Wu S. A Rare Case of Methamphetamine-Induced Diffuse Gastrointestinal Ischemia. Cureus. 2025;17(1):e76857. Published January 3, 2025. Single human case report. DOI: 10.7759/cureus.76857. Publisher full text.